ClinicalTrials.Veeva

Menu

Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain

Connecticut Children's Medical Center logo

Connecticut Children's Medical Center

Status

Completed

Conditions

Sickle Cell Disease
Pain

Study type

Observational

Funder types

Other

Identifiers

NCT01058473
CCMC IRB Number 09-115

Details and patient eligibility

About

Historically, sickle cell disease has not been viewed in the chronic pain paradigm because of its recurrent nature. Patients with sickle cell disease may be hospitalized for extended periods of time. As the hospital stay progresses, patients with SCD pain are often observed by clinicians to have improvements in function in areas such as self-care, mobility, and recreation despite continued self-report of high pain scores. This pattern of functional improvement with continued report of high pain intensity scores is common in patients with recurrent and chronic pain. A functional assessment tool that can assess function in the acute inpatient setting is needed.

The purpose of this study is to evaluate the Inpatient Pediatric Physical Activity Questionnaire (IPPAQ), as a measure of daily function in children with sickle cell disease hospitalized with vasoocclusive pain.

Full description

Refer to Brief Summary

Enrollment

159 patients

Sex

All

Ages

7 to 21 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Documented sickle cell disease
  • Sudden onset of pain consistent with vasoocclusive episode at the time of hospitalization.
  • Pain requiring hospitalization and placement on standard clinical guideline for management of acute pain in sickle cell disease during hospitalization
  • Cognitive ability to report pain on a 0-10 Numerical Rating Scale (NRS)
  • Parental/patient consent and child assent

Exclusion criteria

  • Primary diagnosis other than vasoocclusive pain
  • Concurrent Acute Chest Syndrome (ACS)
  • Patient previously enrolled in this study
  • Inability to understand English

Trial design

159 participants in 1 patient group

Sickle Cell Disease

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems